MedTrace Logo

Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome

NCT01826617 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2015-04-07

No results posted yet for this study

Summary

This study will identify significant clinical parameters and individual risk factors related to certain prostate disease (BPH, prostatitis and prostate cancer). With the identified important correlations, a locally generated bias free nomogram will be constructed for predicting prostate biopsy outcome among Asian men with indications for prostate biopsy. While this study will evaluate the accuracy and predictive value of this novel prostate disease nomogram.

Conditions

Sponsors & Collaborators

  • St. Luke's Medical Center, Philippines

    lead OTHER

Principal Investigators

  • Michael E. Chua, MD · St. Luke's Medical Center, Philippines

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2014-11-30
Completion
2014-12-31

Countries

  • Philippines

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01826617 on ClinicalTrials.gov